Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-03-09

FDA Approved: CEFDINIR — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

The FDA approved a supplemental application for CEFDINIR (cefdinir) from Aurobindo Pharma Limited, a generic cephalosporin antibiotic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cefdinir (cefdinir)

Snippet

SUPPL AP for CEFDINIR (CEFDINIR)